Examples of 'interferon-beta' in a sentence
Meaning of "interferon-beta"
Interferon-beta is a type of protein that plays a role in the immune response and is used in the treatment of certain diseases, such as multiple sclerosis
How to use "interferon-beta" in a sentence
Basic
Advanced
interferon-beta
This may include interferon-beta or steroids.
Antiproliferative activities of alanine substituted interferon-beta mutants.
Recombinant forms of interferon-beta have been produced.
Interferon-beta mutants were also assessed for function in an antiproliferation assay.
Antiviral activities of alanine substituted interferon-beta mutants.
Liquid stabilized interferon-beta formulations in coated pharmaceutical containers.
Pharmaceutical compositions containing interferon-beta are well known.
Administration of interferon-beta also can be performed on strict or adjustable schedules.
All animals must be naive to interferon-beta treatment.
Interferon-beta for use as monotherapy or in combination with other cancer therapies.
Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.
In another embodiment, the biologically active protein or peptide is an interferon-beta.
In some embodiments, the interferon-beta is formulated for subcutaneous injection.
Interferon-beta selectively induces tyrosine phosphorylation of an alpha subunit-associated protein.
Relative antiviral and antiproliferative activities of alanine substituted interferon-beta mutants.
See also
In some embodiments, the interferon-beta is formulated for intramuscular injection.
Thus, siliconized syringes are used for the liquid formulation of interferon-beta.
Other interferon-beta useful in any of the uses of the invention are provided herein.
Particularly preferred is the scaffold attachment region derived from human interferon-beta.
Interferon-beta protein inhibits the growth of renal cell carcinoma cells in culture.
Nerve protein levels also fell when treatment with interferon-beta 1a treatment began.
The recombinant human interferon-beta may contain a free sulfhydryl and at least one disulfide bond.
Both the anti-proliferative and immunomodulatory activities of interferon-beta could be effective in this setting.
Interferon-beta levels were quantitated by use of an ELISA assay.
Preparation of interferon-alpha and interferon-beta has been established by using leukocyte and fibroblast cell.
Interferon-beta and mitoxantrone may also slow the progression of secondary progressive MS.
Treatment with interferon-alpha and interferon-beta have shown some efficacy against several cancers.
Interferon-beta concentrations are determined by absorbance at 278 nm with background subtraction.
DNA and viruses partition from interferon-beta on this column.
Occasionally interferon-beta also induces transient worsening of preexisting MS symptoms.
Method for delivering interferon-beta.
Both Tysabri and interferon-beta treatments were associated with lower length and weight of babies.
In some embodiments according to the invention, the interferon-beta is interferon-beta 1b.
Use of human interferon-beta for the preparation of pharmaceutical compositions for treating Chronic Myeloid Leukemia.
Attempts to develop pills containing Interferon-beta have not been successful so far.
In another embodiment, Gram-negative bacteria may be administered together with interferon-beta.
Treated samples are evaluated for interferon-beta stability by the methods described in Example 1.
To distinguish unoccupied ( free ) receptor from receptor to which interferon-beta was bound.
Dilutions of interferon-beta mutant typically ranged from approximately 1 µM down to 10 pM.
In some embodiments according to the invention, the interferon-beta is interferon-beta 1a.
In some embodiments, the interferon-beta 1b is recombinantly produced in mammalian cells.
A liquid pharmaceutical formulation according to any of the claims 1 or 2, in which interferon-beta is recombinant.
When compared to remaining on interferon-beta alone ( and adding placebo ).
The interferon-beta therapy can be treatment with interferon-beta lb, interferon-beta 1a, or both types of interferon.
The liquid composition of claim 1, wherein the interferon-beta is a recombinantly produced interferon.
For example, an interferon-beta can be modified by deleting, adding or substituting an amino acid.
In some embodiments according to any of the above methods, the interferon-beta is interferon-beta 1b.
While interferon-alpha, interferon-beta and thrombospondin are examples of angiogenesis suppressors.
In some embodiments according to any of the above methods, the interferon-beta is interferon-beta 1a.
Modification of interferon-beta 1a with a non-toxic polymer may offer certain advantages.
